Appropriate funding is crucial for scientific progress, which is especially true in the case of basic science. Fundamental studies do not deliver a final product or potential revenue in a short-term, so the most wealthy stakeholders in R&D – business – are unlikely to invest their money in them.    Studies exploring the main mechanisms…

New medical technologies need bold researchers to make the leap from the laboratory table to hospitals and clinics where they can improve or even save lives. Kelsey Moody, a 30-year-old scientist from Beekmantown, is one such researcher. Kelsey is especially interested in the treatment of age-related diseases but using a different approach. Currently researching age-related…

The development pipeline for new drugs and therapies is a long one, and on average it can take up to 17 years to research, test and bring a new product to market [1]. The reasons for this are myriad and complex, the demanding test phases required for safety and efficacy, the preclinical tests, the regulatory…

Today we have an interesting study showing that the damage to the neurons caused by beta-amyloid associated with Alzheimer’s disease is repaired when the amyloid is removed[1]. This means that removing the amyloids could potentially reverse the symptoms of Alzheimer’s in the early stages of the disease before too much damage is done.  Amyloids are misfolded…

As we recently reported in another blog there has been a lot of interest in the idea that young blood transfused into an old person could be a way to regenerate tissues and reverse some of the damage caused by the aging process.  Today a brand new podcast with Doctors Irina and Michael Conboy was…

© 2017 - LIFE EXTENSION ADVOCACY FOUNDATION
Privacy Policy / Terms Of Use

       Powered by MMD